Accurate classification of metastatic brain tumors using a novel microRNA-based test. Background: LTX-315 (Oncopore) is a chemically designed cationic nonapeptide derived from a natural host defensive ...
A pilot study of docetaxel and carboplatin for treatment of patients with mCRPC containing biallelic inactivation of genes in the BRCA1/2 pathway. This is an ASCO Meeting Abstract from the 2020 ...
OPDIVO is a prescription medicine used in combination with YERVOY as a first treatment to treat adults with cancer of the ...
Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...
Subcutaneous (subQ or SQ) injections are shots given in the fatty tissue layer (subcutaneous fat) under your skin. Your skin has many layers, and the subcutaneous layer is beneath the epidermis and ...
The subcutaneous formulation of Opdivo provides a convenient alternative to intravenous administration for patients with solid tumors, maintaining efficacy and safety. The CHECKMATE-67T trial ...
FDA approved pembrolizumab and berahyaluronidase alfa-pmph for patients aged 12 and older with solid tumors. Study MK-3475A-D77 showed a 45% ORR in subcutaneous administration for treatment-naïve ...
Subcutaneous injections typically cause minimal pain since they involve small, short needles that do not penetrate deeply into the tissue. People may be able to reduce the pain of injections by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results